spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioProcess International West

BioProcess International West

19-22 March 2018

BioProcess International West (BPI West) is the leading phase-based bioprocessing event for advancing promising biologics towards commercial success.  Join 850+ global scientists and key decision makers at our upcoming meeting, held March 19-22, 2018 in San Francisco, CA. 

Keynote presenters on our 2018 agenda include Tony D’Amore (Sanofi Pasteur), Vijay Chiruvolu (Kite Pharma), and Arulvathani Arudchandran (FDA-CDER).

The BPI West 2018 agenda is comprised of four phase-based tracks, designed to bring attendees working across multiple departments together to collectively share challenges and discuss the solutions needed to improve the speed, lower the cost and increase the quality of biologics development.  

Register your team today and access 100+ case study and new data presentations across our four phase-based tracks:

  1. Single-Use/Flexible Facilities
  2. Early Stage Process Development
  3. Late Stage Process Development
  4. Commercial Manufacturing

Additionally, all attendees receive access to our exhibit hall which features 80+ global technology and service providers as well as 40+ peer-submitted scientific posters containing new and unpublished data. 

Save an extra 10% off current rates when you register with VIP code SAMEDANby February 9.  For full program details and to register, visit http://bit.ly/2F29qVt

Questions?  Contact Event Marketing Manager Howie Choi at howard.choi@knect365.com.
phone 888-670-8200 (U.S. Toll-free), +1 941-554-3500 (International)
email howard.choi@knect365.com
web bit.ly/2F29qVt
email Hilton San Francisco Union Square, San Francisco, CA
 
Print this page
Send to a friend
   
Banner of Bio Trinity_Events_Page on Samedan
spacer
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

White Papers

Trial Timelines

Thomson Reuters

Save resources with accurate trial length projections. How analytics based on curated content can deliver insight for clinical strategies.
More info >>


News and Press Releases

PredictImmune announce issuance of new patent in the US in support of commercialisation

PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed its latest patent grant in the US. The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. This follows successful grants across the company’s first family of IP in the UK and Europe in October 2018 and Canada in January this year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement